GlassScriptPhysician profile
Anthony Vito Benenati
NPI 1053358663
$1,835.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $398 · 2021: $314 · 2022: $456 · 2023: $144 · 2024: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $600.44 | 2020-2023 | Anchorage, Ortholoc 2 Lapifuse |
| Kerecis Limited | $285.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Osteomed LLC | $209.01 | 2020-2022 | |
| Treace Medical Concepts, INC. | $162.86 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $137.58 | 2019-2020 | |
| Smith+Nephew, INC. | $122.20 | 2019-2023 | Evos Mini, Vlp Foot, Evos |
| In2bones USA, LLC | $74.71 | 2019 | |
| Pinnacle, INC | $50.28 | 2022-2024 | |
| Medtronic, INC. | $43.94 | 2022 | |
| Wright Medical Technology, INC. | $31.23 | 2019 | |
| Integra Lifesciences Corporation | $28.01 | 2021 | |
| Orthofix Medical, INC. | $24.27 | 2021-2022 | |
| Crossroads Extremity Systems, LLC | $18.70 | 2021 | |
| Paragon 28, INC. | $17.66 | 2022 | |
| Horizon Therapeutics Plc | $14.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $13.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Benenati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.